Enhance Reaction Rates For Anti-Cancer Therapy Manufacture
Source: Asymchem
Photochemical reactions are challenging to use in traditional batch methods because of the unproductive light absorption in large batch reactors. Applying flow chemistry techniques enabled Asymchem to develop a new route for Ceralasertib, an experimental anti-cancer therapy, which included LED-NMR reaction profiling, quantum yield measurements and Stern-Volmer quenching studies--and revealed a potential new way to optimize the catalyst system.
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Asymchem
This website uses cookies to ensure you get the best experience on our website. Learn more